September 19, 2016

Today's Top Alzheimer's News

MUST READS   

A September 18, 2016 Star2.com article reported that “Heathrow Airport has declared itself the world’s first dementia-friendly airport after launching a programme that will train airport staff on how to help travellers suffering from cognitive decline.”

A September 16, 2016 MedicalXpress.com article reported that “New research led by Northeastern University suggests that Alzheimer's disease may not progress like falling dominoes, as conventional wisdom holds, with one molecular event sparking the formation of plaques throughout the brain.” According to the article, “The study, headed by Lee Makowski, professor and chair of the Department of Bioengineering, was publishedThursday in the journal Scientific Reports. ‘I believe the findings will provide us with a new way of thinking about the molecular basis for Alzheimer's disease progression,’ says Makowski. ‘Once you do that, you can start asking the right questions about how to prevent it.’”

A September 16, 2016 MedScape.com interview with Maria Shriver and Dr. Richard Isaacson explored the topic of Alzheimer’s prevention. According to Dr. Isaacson, “For now, our initial published study showed that individualized dietary and lifestyle interventions can result in robust and significant improvements in executive function and processing speed. We were not able to move memory much at all, however; we found no change in memory during the 6 months.”

A September 16, 2016 NPR.org article reported that HHS issued new rules to make clinical trials more transparent. According to the article, “The new rules, published Friday in the Federal Register, are designed to make it easier for scientists, universities and corporations to understand what experiments must be included in the federal database. It also expands the list of studies that must be registered, to include experimental behavioral interventions — such as a study that compares different diets among diabetics — as well as early-stage (Phase 1) drug trials if they have NIH funding.”